scispace - formally typeset
I

Isabelle Richard-Lordereau

Researcher at Bristol-Myers Squibb

Publications -  7
Citations -  371

Isabelle Richard-Lordereau is an academic researcher from Bristol-Myers Squibb. The author has contributed to research in topics: Clinical trial & Implantable cardioverter-defibrillator. The author has an hindex of 4, co-authored 5 publications receiving 339 citations.

Papers
More filters
Journal ArticleDOI

Personalized management of atrial fibrillation

TL;DR: opportunities to personalize management of AF in a better manner with a view to improve outcomes by integrating atrial morphology and damage, brain imaging, information on genetic predisposition, systemic or local inflammation, and markers for cardiac strain are identified.
Journal ArticleDOI

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.

Paulus Kirchhof, +72 more
- 01 Nov 2013 - 
TL;DR: In this article, the authors identified the following opportunities to personalize management of atrial fibrillation in a better manner with a view to improve outcomes by integrating atrial morphology and damage, brain imaging, information on genetic predisposition, systemic or local inflammation, and markers for cardiac strain.
Journal ArticleDOI

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference

Dipak Kotecha, +63 more
- 01 Mar 2018 - 
TL;DR: Sixty-two global specialists in AF and 13 industry partners met to develop innovative solutions based on new approaches to screening and diagnosis, enhancing integration of AF care, developing clinical pathways for treating complex patients, improving stroke prevention strategies, and better patient selection for heart rate and rhythm control.
Journal ArticleDOI

New medicinal products for chronic heart failure: Advances in clinical trial design and efficacy assessment

TL;DR: The Cardiovascular Round Table of the European Society of Cardiology (ESC), in partnership with the Heart Failure Association of the ESC, convened a dedicated two‐day workshop to discuss three main topic areas of major interest in the field and addressed in this draft EMA guideline.
Journal ArticleDOI

Cardiovascular Disease in the Elderly: Proceedings of the European Society of Cardiology-Cardiovascular Round Table.

TL;DR: The growing burden of ageing in real life is demonstrated and the need to continue primary prevention to address cardiovascular risk factors is illustrated, and factors to consider when choosing pharmacological and interventional treatments in the elderly are summarized.